A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

NAActive, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

December 30, 2032

Study Completion Date

December 30, 2032

Conditions
Depression
Interventions
BEHAVIORAL

Open Label Placebo with Rationale

In the OLP + rationale group, the participants will be prescribed to take placebos for 2 weeks with the standard 4-point accompanying rationale: (1) the placebo effect is powerful, e.g. in clinical trials placebos are roughly 80% as effective as antidepressants; (2) classical conditioning is a possible mechanism for automatic self-healing - meaning that the body can automatically respond to taking placebo pills like Pavlov's dogs who salivated when they heard a bell; (3) placebo-treated patients who are more compliant have better outcomes, therefore the placebos should be taken faithfully; and (4) positive expectations increase placebo effects, but it is OK to have doubts.

BEHAVIORAL

Open Label Placebo without Rationale

In the OLP without rationale group, the adolescents will be asked to take placebos for 2 weeks but they will be told that the pills contain inert substance and do not have any pharmacological effect.

Trial Locations (1)

94143

UCSF, San Francisco

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of California, San Francisco

OTHER